Latest stories on CGON
CG Oncology Shares Rise on Third Quarter Beat
MarketWatch67 · bullishearnings
Why is CG Oncology stock surging today?
Investing.com Markets64 · neutralgeneral
CG Oncology reports Q3 EPS (64c), consensus (81c)
The Fly62 · neutralearnings
CG Oncology, Inc. (CGON) files 8-K
SEC 8-K50 · neutralgeneral
CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire58 · neutralearnings
CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates
Business Insider56 · neutralearnings
CG Oncology: A Second-Mover Advantage In Bladder-Sparing Therapy
Seeking Alpha63 · neutralanalyst
CG Oncology appoints Isabel Kalofonos as chief commercial officer
The Fly53 · neutralgeneral
CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer
Business Insider58 · neutralproduct/pr
CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer
GlobeNewswire58 · neutralproduct/pr
Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm
PR Newswire34 · bearishgeneral
CG Oncology, Inc. (CGON) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
CG Oncology to Present at Upcoming Investor Conferences in September
GlobeNewswire56 · neutralgeneral
Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm
PR Newswire42 · neutralgeneral
CG Oncology: Circling Back After Huge Rally
Seeking Alpha73 · bullishproduct/pr
Cg Oncology Price Target Raised To 85 From 82 At Truist
The Fly61 · neutralanalyst
Cg Oncology Price Target Lowered To 79 From 81 At Rbc Capital
The Fly34 · bearishanalyst
CG Oncology, Inc. (CGON) files 8-K
SEC 8-K50 · neutralgeneral
CG Oncology GAAP EPS of -$0.90
Seeking Alpha34 · bearishearnings
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
StockTitan50 · neutralgeneral
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
StockTitan63 · neutralproduct/pr
CG Oncology: Priced To Perfection On Future Pipeline Success
Seeking Alpha56 · neutralanalyst
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter | ANIP Stock News
StockTitan48 · neutralgeneral
CG Oncology, Inc. (CGON) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral